Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
McKesson
Argus Health
Chinese Patent Office
Harvard Business School
Dow
Healthtrust
Merck
Accenture

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020988

« Back to Dashboard

NDA 020988 describes PROTONIX IV, which is a drug marketed by Wyeth Pharms Inc and is included in one NDA. It is available from two suppliers. There are three patents protecting this drug. Additional details are available on the PROTONIX IV profile page.

The generic ingredient in PROTONIX IV is pantoprazole sodium. There are forty-eight drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.
Summary for 020988
Tradename:PROTONIX IV
Applicant:Wyeth Pharms Inc
Ingredient:pantoprazole sodium
Patents:3
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020988
Mechanism of ActionProton Pump Inhibitors
Suppliers and Packaging for NDA: 020988
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROTONIX IV pantoprazole sodium INJECTABLE;IV (INFUSION) 020988 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0008-0923 N 0008-0923-51
PROTONIX IV pantoprazole sodium INJECTABLE;IV (INFUSION) 020988 NDA Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. 0008-0923 N 0008-0923-55

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;IV (INFUSION)StrengthEQ 40MG BASE/VIAL
Approval Date:Mar 22, 2001TE:APRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:May 17, 2022Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Try a Free TrialPatent Expiration:May 17, 2022Product Flag?Substance Flag?Delist Request?Y
Patent:➤ Try a Free TrialPatent Expiration:May 17, 2022Product Flag?Substance Flag?Delist Request?Y

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Citi
QuintilesIMS
Argus Health
US Department of Justice
Queensland Health
Dow
Boehringer Ingelheim
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.